VCF yields 155.52% · JNJ yields 2.14%● Live data
📍 VCF pulled ahead of the other in Year 1
Combined, VCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VCF + JNJ for your $10,000?
Delaware Investments Colorado Municipal Income Fund, Inc. is a closed-ended fixed income mutual fund launched by Delaware Management Holdings, Inc. It is managed by Delaware Management Business Trust. The fund invests in the fixed income markets of the United States. It primarily invests in un-insured, investment grade, tax-exempt Colorado municipal obligations, including airport revenue bonds, city general obligation bonds, continuing care/retirement revenue bonds, convention center/auditorium/hotel revenue bonds, dedicated tax and fees revenue bonds, higher education revenue bonds, hospital revenue bonds, municipal lease revenue bonds, parking revenue bonds, political subdivision general obligation bonds, pre-refunded bonds, school district general obligation bonds, school district revenue bonds, turnpike/toll road revenue bonds, and water and sewer revenue bonds. The fund seeks to maintain an average portfolio maturity of 20 to 30 years. It benchmarks the performance of its portfolio against the Barclays Municipal Bond Index and Lipper CE Other States Municipal Debt Funds Average. Delaware Investments Colorado Insured Municipal Income Fund, Inc. was formed on July 29, 1993 and is domiciled in the United States.
Full VCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.